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ABSTRACT 
Type 2 diabetes mellitus, obesity, genetic factors are linked to insulin resistance. The three factors are linked to each 
other or are independent in causing insulin resistance. Insulin resistance has a harmful effect on the body. It can lead 
to metabolic syndrome, cardiovascular disease patient to increase in number.Combination of drug and lifestyle 
modification are necessary to overcome it. Hence, the basis of treatment in insulin resistance is to introduce healthy 
lifestyle and exercise, as exercise increases the sensitivity of insulin receptor. 
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Introduction 
 
 
Insulin resistance is a physiological condition in which 
body produces normal amount of insulin, but the cells 
fail to respond to the normal actions of the hormone 
insulin effectively, leading to hyperglycemia.This leads 
toincrease production of insulin from β-cells in the 
pancreas, further contributing to hyperinsulinemic 
state.In general,it remains undetected and can 
contribute to a diagnosis of type 2 diabetes. 
One of the important functions of insulin is to regulate 
delivery of glucose into cells to provide them with 
energy[1]. Insulin resistant cells cannot take in glucose, 
amino acids and fatty acids. A decrease in 
insulin/glucagon ratio inhibits glycolysis, which in turn 
decreases energyproduction. The resulting increase in 
blood glucose may raise levels outside the normal 
range and cause adverse health effects, depending on 
dietary conditions[2]. 
Certain cells like fat and muscle cells absorbs glucose 
in presence of insulin. When these cells fail to respond 
adequately to circulating insulin, blood glucose levels 
rise. The liver helps regulate glucose levels by reducing 
its secretion of glucose in the presence of insulin [3]. 
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Insulin resistance in muscle and fat cells reduces 
glucose uptake, whereas in liver cells it reduced 
glycogen synthesis and storage and a fails to suppress 
glucose production and release into the blood. Insulin 
resistance normally refers to reduced glucose-lowering 
effects of insulin. It also effects other functions of 
insulin, asin fat cells it results in reduced uptake of 
circulating lipids and increased hydrolysis of stored 
triglycerides. Increased mobilization of stored lipids in 
these cells elevates free fatty acids in the blood plasma. 
Elevated blood fatty-acid concentrations, reduced 
muscle glucose uptake, and increased liver glucose 
production all contribute to elevated blood glucose 
levels. Themajor component of the metabolic 
syndrome is high plasma levels of insulin and glucose 
due to insulin resistance. This insulin resistance will 
make the pancreas to increase the secretion of insulin 
by compensatory mechanism. If thiscompensatory 
mechanism fails, blood glucose levels increase and 
leads to development of type 2 diabetes mellitus 
(T2DM) [4]. 
Pathophysiology 
Any food or drink containing glucose causes blood 
glucose levels to increase. In a normal metabolism, the 
elevated blood glucose level makes β-cells in the Islets 
of Langerhans, located in the pancreas, release insulin 
into the blood. The insulin, in turn, makes insulin-
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sensitive tissues in the body absorb glucose, and 
thereby lower the blood glucose level. The β-cells 
reduce insulin output as the blood glucose level falls, 
allowing blood glucose to settle at a constant of. In an 
insulin-resistantperson, normal levels of insulin do not 
have the same effect in controlling blood glucose 
levels. During the compensated phase on insulin 
resistance insulin levels are higher, and blood glucose 
levels are still maintained. If compensatory insulin 
secretion fails, then either fasting or postprandial 
glucose concentrations increase. Eventually, type 2 
diabetes occurs when glucose levels become higher 
throughout the day as the resistance increases and 
compensatory insulin secretion fails. 
The most common type of insulin resistance is 
associated with overweight and obesity in a condition 
known as metabolic syndrome. Insulin resistance often 
progresses to full T2DM. This is often seen when 
hyperglycemia develops after a meal, when pancreatic 
β-cells are unable to produce sufficient insulin to 
maintain normal blood sugar levels (euglycemia) in the 
face of insulin resistance. The inability of the β-cells to 
produce sufficient insulin in a condition of 
hyperglycemia is what characterizes the transition from 
insulinresistance to T2DM [5]. 
Insulin itself leads to a kind of insulin resistance; every 
time a cell is exposed to insulin, the production of 
GLUT4 on the cell’s membrane decreases somewhat 
[6].In the presence of a higher than usual level of 
insulin (generally caused by insulin resistance), this 
down-regulation acts as a kind of positive feedback, 
increasing the need for insulin. Exercise reverses this 
process in muscle tissue [7], but if it is left unchecked, 
it can contribute to insulin resistance. 
Insulin resistance is often found in people with visceral 
adiposity (i.e., a high degree of fatty tissue within the 
abdomen – as distinct from subcutaneous adiposity or 
fat between the skin and the muscle wall, especially 
elsewhere on the body, such as hips or thighs), 
hypertension, hyperglycemia and dyslipidemia 
involving elevatedtriglycerides, small dense low-
density lipoprotein (LDL) particles, and decreased 
high-density lipoprotein cholesterol levels. With 
respect to visceral adiposity, a great deal of evidence 
suggests two strong links with insulin resistance. First, 
unlike subcutaneous adipose tissue, visceral adipose 
cells produce significant amounts of proinflammatory 
cytokines such as tumor necrosis factor-alpha, and 
interleukins-1 and -6, etc. In numerous experimental 
models, these proinflammatory cytokines disrupt 
normal insulin action in fat and muscle cells, and may 
be a major factor in causing the whole-body insulin 
resistance observed in patients with visceral adiposity. 
Much of the attention on production of 
proinflammatory cytokines has focused on the IKK-
β/NF-kappa-B pathway, a protein network that 
enhances transcription of inflammatory markers and 
mediators that can cause insulin resistance. Second, 
visceral adiposity is related to an accumulation of fat in 
the liver, a condition known as nonalcoholic fatty liver 
disease (NAFLD). The result of NAFLD is an 
excessive release of free fatty acids into the 
bloodstream (due to increased lipolysis), and an 
increase in hepatic glycogenolysis and hepatic glucose 
production, both of which have the effect of 
exacerbating peripheral insulin resistance and 
increasing the likelihood of T2DM. 
Insulin resistance is also occasionally found in patients 
who use insulin. With the development of human 
insulin and analogues in the 1980s and the decline in 
the use of animal insulins(such as pork or beef), this 
type of insulin resistance has become less common. 
This form of insulin resistance is not what is being 
referred to in the metabolic syndrome. 
Magnesium (Mg) is present in living cells and its 
plasma concentration is remarkably constant in healthy 
subjects. Plasma and intracellular Mg concentrations 
are tightly regulated. Among the controlling 
mechanisms, insulin seems to be one of the most 
important. In vitro and in vivo studies have 
demonstrated that insulin may modulate the shift of Mg 
from extracellular to intracellular space. Intracellular 
Mg concentration has also been shown to be effective 
in modulating insulin action (mainly oxidative glucose 
metabolism), offset calcium-related excitation 
contraction coupling, and decrease smooth cell 
responsiveness to depolarizing stimuli. Poor 
intracellular Mg concentrations, as found in T2DM and 
in hypertensive patients, may result in a defective 
tyrosine-kinase activity at the insulin receptor level and 
exaggerated intracellular calcium concentration. Both 
events are responsible for impairment in insulin action, 
and a worsening of insulin resistance in noninsulin 
dependent diabetic and hypertensive patients. By 
contrast, in T2DM patients daily Mg administration, 
restoring a more appropriate intracellular Mg 
concentration, contributes to improve insulin-mediated 
glucose uptake. The benefits deriving from daily Mg 
supplementation in T2DM patients are further 
supported by epidemiological studies showing that 
high daily Mg intake are predictive of a lower 
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incidence of T2DM. 
Causes of Insulin Resistance 
Molecular 
Insulin resistance has been proposed at a molecular 
level to be a reaction to excess nutrition by superoxide 
dismutase in cell mitochondria that acts as an 
antioxidant defense mechanism. This link seems to 
exist under diverse causes of insulin resistance. It is 
also based on the finding that insulin resistance can be 
rapidly reversed by exposing cells to mitochondrial 
uncouplers, electron transport chain inhibitors, or 
mitochondrial superoxide dismutase mimetics [8]. 
Cellular 
At the cellular level, much of the variance in insulin 
sensitivity between untrained, non-diabetic humans is 
explained by two mechanisms: Differences in 
phospholipid profiles of skeletal muscle cell 
membranes, and in intramyocellular lipid stores within 
these cells [9]. High levels of lipids in the bloodstream 
have thepotential to result in accumulation of 
triglycerides and their derivatives within muscle cells, 
which activate proteins Kinase C-ε and C-θ, ultimately 
reducing the glucose uptake at any given level of 
insulin[10,11]. This mechanism is quite fast-acting and 
can induce insulin resistance within days or even hours 
in response to a large lipid influx [12]. Draining the 
intracellular reserves, on the other hand, is more 
challenging: moderate caloric restriction alone, even 
over a period of several months, appears to be 
ineffective [13,14], and it must be combined with 
physical exercise to have any effect. 
In the long term, diet has the potential to change the 
ratio of polyunsaturated to saturated phospholipids in 
cell membranes, correspondingly changing cell 
membrane fluidity; full impact of such changes is not 
fully understood, but it is known that the percentage of 
polyunsaturated phospholipids is strongly inversely 
correlated with insulin resistance [15]. It is 
hypothesized that increasing cell membrane fluidity by 
increasing polyunsaturated fatty acidconcentration 
might result in an enhanced number of insulin 
receptors, an increased affinity of insulin to its 
receptors and a reduced insulin resistance, and vice 
versa [16].Many stressing factors can lead to increased 
cortisol in the bloodstream. Cortisol counteracts 
insulin, and contributes to hyperglycemia-causing 
hepatic gluconeogenesis[17] and inhibits the peripheral 
utilization of glucose, which eventually leads to insulin 
resistance [17]. It does this by decreasing the 
translocation of glucosetransporters (especially 
GLUT4) to the cell membrane [18,19]. Although 
inflammation is often caused by cortisol, inflammation 
by itself also seems to be implicated in causing insulin 
resistance. 
Diet 
Insulin resistance and obesity commonly coexists. The, 
causal links between insulin resistance, obesity, and 
dietary factors are complex and controversial. It is 
possible that one of them arises first, and tends to cause 
the other. Itis also possible that insulin resistance and 
excess body weight might arise independently as 
aconsequence of a third factor, and at last reinforcing 
each other. Some population groups might be 
genetically predisposed to one or the other. Dietary fat 
has long been implicated as a driver of insulin 
resistance. Studies on animals observed 
significantinsulin resistance in rats after just 3 weeks 
on a high-fat diet[10], but saturated fat appears to be 
the most effective at producing insulin resistance[20]. 
In humans, statistical evidence is more equivocal. 
Being insensitive to insulin is positively correlated with 
fat intake, and negatively correlated with dietary fiber 
intake[21]. The effect of dietary fat is largely or 
completely overridden if the high-fat diet is modified 
to contain nontrivial quantities of polyunsaturated 
omega-3 fatty acids[20,22,23]. This protective effect is 
most established with regard to the so-called “marine 
long-chain omega-3 fatty acids,”eicosapentaenoic acid 
and docosahexaenoic acid, found in fish oil; evidence 
in favor of other omega-3's, in particular, the most 
common vegetable based omega-3 fatty acid, alpha-
linolenic acid (ALA), also exists [24], but it is more 
limited; some studies find ALA only effective among 
people with insufficient long-chain omega-3 intake 
[25], and some studies fail to find any effect at all[26]. 
Elevated levels of free fatty acids and triglycerides in 
the blood stream and tissues have been found in many 
studies to contribute to diminished insulin 
sensitivity[20,27-29]. Triglyceride levels are driven by 
a variety of dietary factors. They are correlated with 
excess body weight [30]. They tend to rise due to 
overeating and fall during fat loss [31]. At constant 
energy intake, triglyceride levels are positively 
correlated with trans-fat intake and strongly inversely 
correlated with omega-3 intake. High-carbohydrate, 
low-fat diets were found by many studies to result in 
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elevated triglycerides [32], in part due to higher 
production of very LDL from fructose and sucrose, and 
in part because increased carbohydrate intake tends to 
displace some omega-3 from the diet. Several recent 
authors suggested that the intake of simple sugars, and 
particularly fructose, is also a factor that contributes to 
insulin resistance[33,34]. Fructose is metabolized by 
the liver into triglycerides, and, as mentioned above, 
tends to raise their levels in the blood stream. 
Therefore, it may contribute to insulin resistance 
through the same mechanisms as the dietary fat. Just 
like fat, high levels of fructose and/or sucrose induce 
insulin resistance in rats [35,36], and, just like with fat, 
this insulin resistance is ameliorated by fish oil 
supplementation[37]. One study observed that a low-fat 
diet high in simple sugars but not in 
complexcarbohydrates and starches significantly 
stimulates fatty acid synthesis, primarily of the 
saturated fatty acid palmitate, therefore, paradoxically, 
resulting in the plasma fatty acid pattern that is similar 
to that produced by a high-saturated-fat diet[38]. It 
should be pointed out that virtually all evidence of 
deleterious effects of simplesugars so far is limited to 
their concentrated formulations and sweetened 
beverages. In particular, very little is known about 
effects of simple sugars in whole fruit and vegetables. 
If anything, epidemiological studies suggest that their 
high consumption is associated with somewhat lower 
risk of IR and/or metabolic syndrome [39,40]. 
Some proposed mechanism involves the phenomenon 
known as leptin resistance. Leptin is a hormone that 
regulates long-term energy balance in many mammals. 
An important role of leptin is long-term inhibition of 
appetite in response to formation of body fat. This 
mechanism is known to be disrupted in many obese 
individuals: Even though their leptin levels are 
commonly elevated, this does not result in reduction of 
appetite and caloric intake [41]. 
As elevated blood glucose levels are the primary 
stimulus for insulin secretion and production, 
habitually excessive carbohydrate intake is another 
likely contributor. Furthermore, carbohydrates are not 
equally absorbed. Integrated blood glucose response to 
a fixed quantity of carbohydrates in a meal is known as 
glycemic index. Some diets are based on this concept, 
assuming that consumption of low-GI foods is less 
likely to result in insulin resistance and obesity. 
However, small to moderate amounts of simple sugars 
(i.e., sucrose, fructose, and glucose) in the typical 
developed-world diet seem to not have a causative 
effect on the development of insulin resistance [42]. 
Studies show that high levels of cortisol within the 
bloodstream from the digestion of animal protein can 
contribute to the development of insulin resistance 
[43,44].In addition, animal protein, because of its high 
content of purine, causes blood pH to become acidic. 
Several studies conclude that high uric acid levels, 
apart from other contributing factors, by itself may be a 
significant cause of insulin resistance [45]. Vitamin D 
deficiency is also associated with insulin resistance 
[46]. 
Insulin resistance can also be induced by a low 
carbohydrate high fat diet in which it is termed 
physiological insulin resistance. This form of insulin 
resistance is not considered a diabetes marker and can 
be recovered from by introducing a sufficient amount 
of carbohydrate to the diet for a few days (100-150 g of 
carbohydrates). Whiledieting, fatty muscle tissue 
breakdown releases non esterified fatty acids that are 
mostly taken by the muscle cells as fuel and 
automatically inducing insulin resistance in those 
muscles. 
Sedentary lifestyle 
Sedentary lifestyle increases the likelihood of 
development of insulin resistance[47,48]. A different 
study found that vigorous exercise at least once a week 
reduced the risk of type 2 diabetes in women by 33% 
[49]. 
Protease inhibitors 
Protease inhibitors found in HIV drugs are linked to 
insulin resistance [50]. 
HCV and insulin resistance 
Hepatitis C also makes people three to four times more 
likely to develop type 2 diabetes and insulin 
resistance[51]. In addition, “people with Hepatitis C 
who develop diabetes probably have susceptible 
insulinproducing cells, and would probably get it 
anyway - but much later in life [51]. The extra insulin 
resistance caused by Hepatitis C apparently brings on 
diabetes at 35 or 40, instead of 65 or 70[51].” 
Diagnosis 
Fasting insulin levels 
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A fasting serum insulin level of greater than the upper 
limit of normal for the assay is used which is 
approximately 60pmol/L 
Glucose tolerance testing (GTT) 
A fasting patient takes a 75 g oral dose of glucose. 
Blood glucose levels are then measured over the 
following 2h. Interpretation is based on WHO 
guidelines. After 2 h a glucose level<7.8 mmol/L (140 
mg/dl) is considered normal, a glycemia of between 7.8 
and 11.0 mmol/L (140-197 mg/dl) is considered as 
impairedglucose tolerance and a glycemia of ≥11.1 
mmol/L (200 mg/dl) is considered diabetes mellitus. 
An oral GTT can be normal or mildly abnormal in 
simple insulin resistance. 
Measuring insulin resistance 
Hyperinsulinemiceuglycemic clamp 
The gold standard for investigating and quantifying 
insulin resistance is the “hyperinsulinemiceuglycemic 
clamp,” so-called because it measures the amount of 
glucose necessary to compensate for an increased 
insulin level without causing hypoglycemia [52]. It is a 
type of glucose clamp technique. The test is rarely 
performed in clinical care, but is used in medical 
research, to assess the effects of different medications. 
The rate of glucose infusion is commonly referred to in 
diabetes literature as the GINF value [53]. The 
procedure takes about 2 h. Through a peripheral vein, 
insulin is infused at 10-120 mU/m2/min. In order to 
compensate for the insulin infusion, glucose 20% is 
infused to maintain blood sugar levels between 5 and 
5.5 mmol/l. The rate of glucose infusion is determined 
by checking the blood sugar levels every 5-10 min. 
Low-dose insulin infusions are more useful for 
assessing the response of the liver, whereas high dose 
insulin infusions are useful for assessing peripheral 
(i.e., muscle and fat) insulin action [53]. 
The rate of glucose infusion during the last 30 min of 
the test determines insulin sensitivity. If high levels 
(7.5 mg/min or higher) are required, the patient is 
insulin-sensitive. Very low levels (4.0 mg/min or 
lower) indicate that the body is resistant to insulin 
action. Levels between 4.0 and 7.5 mg/min are not 
definitive and suggest “impaired glucose tolerance,” an 
early sign of insulin resistance [53]. 
This basic technique can be significantly enhanced by 
the use of glucose tracers. Glucose can be labeled 
witheither stable or radioactive atoms. Commonly-used 
tracers are 3-3H glucose (radioactive), 6,6 2H-
glucose(stable) and 1-13C glucose (stable). Prior to 
beginning the hyperinsulinemic period, a 3h tracer 
infusion enablesone to determine the basal rate of 
glucose production. During the clamp, the plasma 
tracer concentrationsenable the calculation of whole-
body insulin-stimulated glucose metabolism, as well as 
the production of glucoseby the body (i.e., endogenous 
glucose production) [53]. 
Alternatives 
Given the complicated nature of the “clamp” technique 
(and the potential dangers of hypoglycemia in some 
patients), alternatives have been sought to simplify the 
measurement of insulin resistance. The first was the 
Homeostatic Model Assessment (HOMA), and a more 
recent method is the Quantitative insulin sensitivity 
check index (QUICKI). Both employ fasting insulin 
and glucose levels to calculate insulin resistance and 
both correlate reasonably with the results of clamping 
studies. Wallace et al. point out that QUICKI is the 
logarithm of the value from one of the HOMA 
equations [54]. 
Management 
The primary treatment for insulin resistance is exercise 
and weight loss. Low-glycemic load diet has also been 
shown to help [55]. Both metformin and the 
thiazolidinediones improve insulin resistance, but are 
only approved therapies for type 2 diabetes, not insulin 
resistance. By contrast, growth hormone replacement 
therapy may be associated with increased insulin 
resistance [56]. 
Metformin has become one of the more commonly 
prescribed medications for insulin resistance, and 
currently a newer drug, exenatide, is being used. 
Exenatide has not been approved in the UK except for 
use in diabetics, but often improves insulin resistance 
in healthy individuals by the same mechanism as it 
doesin diabetics. 
The diabetes prevention programshowed that exercise 
and diet were nearly twice as effective as metformin at 
reducing the risk of progressing to type 2 diabetes [57]. 
One 2009 study has found that carbohydrate deficit 
after exercise, but not energy deficit, contributed to 
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insulin sensitivity increase [58]. Resistant starch from 
high amylase corn has been shown to reduce insulin 
resistance in healthy individuals, and in individuals 
with type 2 diabetes [59,60]. Animal studies 
demonstrate that it cannot reverse insulin resistance, 
but that it reduces the development of insulin resistance 
[61]. 
Some types of monounsaturated fatty acids, saturated, 
and trans fats promote insulin resistance. Some types of 
polyunsaturated fatty acids (omega-3) can moderate the 
progression of insulin resistance into type 2 diabetes 
[62]. However, omega-3 fatty acids appear to have 
limited ability to reverse insulin resistance, and they 
cease to be efficacious once type 2 diabetes is 
established [63]. 
Caffeine intake limits insulin action, but not enough to 
increase blood sugar levels in healthy persons. People 
who already have diabetes II can see a small increase 
in levels if they take 2 or 21/2 cups of coffee per day 
[64]. 
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